A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects With a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial

Trial Profile

A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects With a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Nov 2017

At a glance

  • Drugs Mepolizumab (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms Asthma
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 20 Nov 2017 Status changed from active, no longer recruiting to completed.
    • 08 Nov 2017 This trial has been completed in Belgium (End Date:2017-10-05).
    • 28 Oct 2017 This trial has been completed in Czech Republic.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top